Archive · 2 Oct 2025
Ozempic Approved in India: Diabetes and Weight Loss
Ozempic, a weekly injection, is now available in India for people with type 2 diabetes.
It helps control blood sugar and can also help with weight loss.
It works like a natural hormone, slowing digestion and making you feel full.
While it offers benefits, it can cause side effects like nausea.
It is essential to take this drug under medical supervision and not casually for cosmetic weight loss.
The price in India is expected to be high, and generic versions may become available in March 2026.
Ozempic (semaglutide) is approved in India.
The drug is a once-weekly injection for adults with type 2 diabetes.
It helps manage blood sugar levels and can aid weight loss.
Common side effects include gastrointestinal issues.
Ozempic is not intended for unsupervised cosmetic weight loss and requires medical supervision.
- Who
- Ozempic
- What
- Approved for type 2 diabetes treatment
- When
- Recently approved
- Where
- India
- Why
- To help treat adults with type 2 diabetes and aid weight loss
Concerns
Benefits
Use
Concerns
Concerns about misuse, potential side effects, and the need for medical supervision.
Benefits
Effective in managing blood sugar and aiding weight loss, potentially improving cardiovascular health.
Accessibility
Concerns
High cost could limit access to only wealthier patients.
Benefits
Potential for wider access through insurance, government programs, or generic versions after 2026.
- Drug Name
- Ozempic (semaglutide)
- Approval
- Approved in India
- Approved Use
- Type 2 Diabetes
- Administration
- Weekly injection
- Potential Benefit
- Weight Loss
- Potential Risk
- Gastrointestinal issues, other complications
Sources
Ozempic coming soon in India: What is it? Benefits, side effects and controversies
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
With Ozempic Hitting India, We Answer All Your Top Questions About The Much Anticipated Weight Loss Drug - From Cost To Risks
As Ozempic Enters Indian Drug Market, Doctor Warns Of 'Misuse' And 'Shortage'
